Literature DB >> 31776273

Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4+ T Cell Subsets during Long-Term Combination Antiretroviral Therapy.

Bradley R Jones1,2, Rachel L Miller3, Jeffrey B Joy1,2,4, Zabrina L Brumme5,3, Natalie N Kinloch1,3, Olivia Tsai3, Hawley Rigsby6, Hanwei Sudderuddin1,3, Aniqa Shahid1,3, Bruce Ganase1, Chanson J Brumme1,4, Marianne Harris1, Art F Y Poon7, Mark A Brockman1,3, Rémi Fromentin6, Nicolas Chomont6,8.   

Abstract

The HIV reservoir, which comprises diverse proviruses integrated into the genomes of infected, primarily CD4+ T cells, is the main barrier to developing an effective HIV cure. Our understanding of the genetics and dynamics of proviruses persisting within distinct CD4+ T cell subsets, however, remains incomplete. Using single-genome amplification, we characterized subgenomic proviral sequences (nef region) from naive, central memory, transitional memory, and effector memory CD4+ T cells from five HIV-infected individuals on long-term combination antiretroviral therapy (cART) and compared these to HIV RNA sequences isolated longitudinally from archived plasma collected prior to cART initiation, yielding HIV data sets spanning a median of 19.5 years (range, 10 to 20 years) per participant. We inferred a distribution of within-host phylogenies for each participant, from which we characterized proviral ages, phylogenetic diversity, and genetic compartmentalization between CD4+ T cell subsets. While three of five participants exhibited some degree of proviral compartmentalization between CD4+ T cell subsets, combined analyses revealed no evidence that any particular CD4+ T cell subset harbored the longest persisting, most genetically diverse, and/or most genetically distinctive HIV reservoir. In one participant, diverse proviruses archived within naive T cells were significantly younger than those in memory subsets, while for three other participants we observed no significant differences in proviral ages between subsets. In one participant, "old" proviruses were recovered from all subsets, and included one sequence, estimated to be 21.5 years old, that dominated (>93%) their effector memory subset. HIV eradication strategies will need to overcome within- and between-host genetic complexity of proviral landscapes, possibly via personalized approaches.IMPORTANCE The main barrier to HIV cure is the ability of a genetically diverse pool of proviruses, integrated into the genomes of infected CD4+ T cells, to persist despite long-term suppressive combination antiretroviral therapy (cART). CD4+ T cells, however, constitute a heterogeneous population due to their maturation across a developmental continuum, and the genetic "landscapes" of latent proviruses archived within them remains incompletely understood. We applied phylogenetic techniques, largely novel to HIV persistence research, to reconstruct within-host HIV evolutionary history and characterize proviral diversity in CD4+ T cell subsets in five individuals on long-term cART. Participants varied widely in terms of proviral burden, genetic diversity, and age distribution between CD4+ T cell subsets, revealing that proviral landscapes can differ between individuals and between infected cell types within an individual. Our findings expose each within-host latent reservoir as unique in its genetic complexity and support personalized strategies for HIV eradication.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CD4+ T cells; HIV; cell subsets; cellular subsets; genetic compartmentalization; human immunodeficiency virus; persistence; proviral age; reservoir

Mesh:

Substances:

Year:  2020        PMID: 31776273      PMCID: PMC7022348          DOI: 10.1128/JVI.01786-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  HIV-1 integration landscape during latent and active infection.

Authors:  Lillian B Cohn; Israel T Silva; Thiago Y Oliveira; Rafael A Rosales; Erica H Parrish; Gerald H Learn; Beatrice H Hahn; Julie L Czartoski; M Juliana McElrath; Clara Lehmann; Florian Klein; Marina Caskey; Bruce D Walker; Janet D Siliciano; Robert F Siliciano; Mila Jankovic; Michel C Nussenzweig
Journal:  Cell       Date:  2015-01-29       Impact factor: 41.582

2.  Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus.

Authors:  Hiromi Imamichi; Ven Natarajan; Joseph W Adelsberger; Catherine A Rehm; Richard A Lempicki; Biswajit Das; Allison Hazen; Tomozumi Imamichi; H Clifford Lane
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

3.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

4.  Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.

Authors:  Francesco R Simonetti; Michele D Sobolewski; Elizabeth Fyne; Wei Shao; Jonathan Spindler; Junko Hattori; Elizabeth M Anderson; Sarah A Watters; Shawn Hill; Xiaolin Wu; David Wells; Li Su; Brian T Luke; Elias K Halvas; Guillaume Besson; Kerri J Penrose; Zhiming Yang; Richard W Kwan; Carter Van Waes; Thomas Uldrick; Deborah E Citrin; Joseph Kovacs; Michael A Polis; Catherine A Rehm; Robert Gorelick; Michael Piatak; Brandon F Keele; Mary F Kearney; John M Coffin; Stephen H Hughes; John W Mellors; Frank Maldarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

5.  The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation.

Authors:  Melissa-Rose Abrahams; Sarah B Joseph; Nigel Garrett; Lynn Tyers; Matthew Moeser; Nancie Archin; Olivia D Council; David Matten; Shuntai Zhou; Deelan Doolabh; Colin Anthony; Nilu Goonetilleke; Salim Abdool Karim; David M Margolis; Sergei Kosakovsky Pond; Carolyn Williamson; Ronald Swanstrom
Journal:  Sci Transl Med       Date:  2019-10-09       Impact factor: 17.956

6.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

7.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2014-01-21       Impact factor: 6.937

8.  Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.

Authors:  James B Whitney; Alison L Hill; Srisowmya Sanisetty; Pablo Penaloza-MacMaster; Jinyan Liu; Mayuri Shetty; Lily Parenteau; Crystal Cabral; Jennifer Shields; Stephen Blackmore; Jeffrey Y Smith; Amanda L Brinkman; Lauren E Peter; Sheeba I Mathew; Kaitlin M Smith; Erica N Borducchi; Daniel I S Rosenbloom; Mark G Lewis; Jillian Hattersley; Bei Li; Joseph Hesselgesser; Romas Geleziunas; Merlin L Robb; Jerome H Kim; Nelson L Michael; Dan H Barouch
Journal:  Nature       Date:  2014-07-20       Impact factor: 49.962

9.  Establishment and stability of the latent HIV-1 DNA reservoir.

Authors:  Johanna Brodin; Fabio Zanini; Lina Thebo; Christa Lanz; Göran Bratt; Richard A Neher; Jan Albert
Journal:  Elife       Date:  2016-11-15       Impact factor: 8.140

10.  Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality.

Authors:  Sarah B Laskey; Christopher W Pohlmeyer; Katherine M Bruner; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2016-08-05       Impact factor: 6.823

View more
  9 in total

1.  Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinoma.

Authors:  Taro Teshima; Yukari Kobayashi; Taketo Kawai; Yoshihiro Kushihara; Koji Nagaoka; Jimpei Miyakawa; Yoshiyuki Akiyama; Yuta Yamada; Yusuke Sato; Daisuke Yamada; Nobuyuki Tanaka; Tatsuhiko Tsunoda; Haruki Kume; Kazuhiro Kakimi
Journal:  Oncol Lett       Date:  2022-06-16       Impact factor: 3.111

2.  Limited HIV-1 Subtype C nef 3'PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana.

Authors:  Kaelo K Seatla; Dorcas Maruapula; Wonderful T Choga; Olorato Morerinyane; Shahin Lockman; Vladimir Novitsky; Ishmael Kasvosve; Sikhulile Moyo; Simani Gaseitsiwe
Journal:  Pathogens       Date:  2021-08-13

3.  HIV-1 variants are archived throughout infection and persist in the reservoir.

Authors:  Kelsie Brooks; Bradley R Jones; Dario A Dilernia; Daniel J Wilkins; Daniel T Claiborne; Samantha McInally; Jill Gilmour; William Kilembe; Jeffrey B Joy; Susan A Allen; Zabrina L Brumme; Eric Hunter
Journal:  PLoS Pathog       Date:  2020-06-03       Impact factor: 6.823

Review 4.  Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection.

Authors:  Chuen-Yen Lau; Matthew A Adan; Frank Maldarelli
Journal:  Viruses       Date:  2021-12-14       Impact factor: 5.048

5.  HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.

Authors:  F Harrison Omondi; Hanwei Sudderuddin; Aniqa Shahid; Natalie N Kinloch; Bradley R Jones; Rachel L Miller; Olivia Tsai; Daniel MacMillan; Alicja Trocha; Mark A Brockman; Chanson J Brumme; Jeffrey B Joy; Richard Liang; Bruce D Walker; Zabrina L Brumme
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

6.  Simulating within host human immunodeficiency virus 1 genome evolution in the persistent reservoir.

Authors:  Bradley R Jones; Jeffrey B Joy
Journal:  Virus Evol       Date:  2020-11-23

7.  Assessment of HIV-1 integration in tissues and subsets across infection stages.

Authors:  Vincent H Wu; Christopher L Nobles; Leticia Kuri-Cervantes; Kevin McCormick; John K Everett; Son Nguyen; Perla M Del Rio Estrada; Mauricio González-Navarro; Fernanda Torres-Ruiz; Santiago Ávila-Ríos; Gustavo Reyes-Terán; Frederic D Bushman; Michael R Betts
Journal:  JCI Insight       Date:  2020-10-15

8.  IFI27 is a potential therapeutic target for HIV infection.

Authors:  Huijuan Huang; Jiannan Lv; Yonglun Huang; Zhiyi Mo; Haisheng Xu; Yiyang Huang; Linghui Yang; Zhengqiu Wu; Hongmian Li; Yaqin Qin
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 9.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.